Professor Andrea Necchi on the clinical impact of NMIBC progression to MIBC- Media Medic

MediaMedic posted on LinkedIn:

“At the recent ESMO Congress, significant discussions were held on the progression of Non-Muscle Invasive Bladder Cancer (NMIBC) to Muscle-Invasive Bladder Cancer (MIBC). This progression has profound implications for our clinical treatment strategies.

Oncology Frontier had the privilege of interviewing Professor Andrea Necchi on-site at ESMO. In this exclusive interview, Professor Necchi delves into the latest research findings, the clinical impact of NMIBC progression to MIBC, and what this means for future treatment protocols.”

View the video attached to the post.
Source: MediaMedic/LinkedIn